August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- As Trump Sits on Key Epstein Files, Wyden Lays Out “Follow the Money” Investigation for DOJ
- Across the Country, Health Insurance Premiums Set to Spike Thanks to Trumpcare
- Wyden Statement on HHS and Treasury Department Nominees at Finance Committee Hearing
- Ahead of committee vote, Wyden opposes Treasury and USTR nominees
- Bipartisan Delegation Urges De-Escalation of US-Canada Trade Conflict In Meeting with Canadian Prime Minister Carney